| Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 20 Nov 25 | IBIO iBio | Stock Option Common Stock | Grant | Acquire A | No | No | 1 | 13,500 | 13.50 k | 13,500 |
| 26 Jun 25 | CTNM Contineum Therapeutics, Inc. Class A Common Stock | Stock Option Class A Common Stock | Grant | Acquire A | No | No | 4.01 | 14,750 | 59.15 k | 14,750 |
| 7 Mar 25 | LENZ LENZ Therapeutics | Common Stock | Option exercise | Acquire M | No | No | 1.04 | 4,200 | 4.37 k | 49,200 |
| 7 Mar 25 | LENZ LENZ Therapeutics | Stock Option Common Stock | Option exercise | Dispose M | No | No | 1.04 | 4,200 | 4.37 k | 337,906 |
| 9 Jan 25 | LENZ LENZ Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 26.34 | 279,100 | 7.35 mm | 279,100 |
| 21 Nov 24 | IBIO iBio | Stock Option Common Stock | Grant | Acquire A | No | No | 2.45 | 18,900 | 46.31 k | 18,900 |
